Biofrontera- Warrants (27/10/2026) Profit Margin

The latest profit margin for BFRIW is -25.66% as of March 2026. That compares with -30.34% in the prior-year period — up 15.4% year over year. That is below the Healthcare sector average of 15.29%. Investors often review this figure alongside Biofrontera- Warrants (27/10/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BFRIW's profit margin moved from -30.34% to -25.66% — a 15.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biofrontera- Warrants (27/10/2026)'s valuation or profitability profile.

Against Healthcare companies, BFRIW currently prints -25.66% for profit margin, while the sector average sits near 15.29%. That is roughly 267.8% below the sector mean. Large gaps often invite a closer look at Biofrontera- Warrants (27/10/2026)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Biofrontera- Warrants (27/10/2026) converts resources into returns. At -25.66%, BFRIW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -30.34% in the prior-year period — up 15.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BFRIW's profit margin (-25.66%), review year-over-year change from -30.34%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.